In addition to those “AR-dependent” castration-resistant adenocarcinomas, a subset of patients was found to progress in AR-independent cancer biology, with short-term responses to hormone therapy, early and widespread metastases, and poor outcomes. Here, AR is linked to adenocarcinoma.